Promising results mean coronavirus vaccine trial could start by August

loading...

Promising results mean coronavirus vaccine trial could start by august

(HealthDay)—Animal studies of a potential COVID-19 vaccine have been so encouraging that researchers plan to speed up testing of the vaccine in humans.

Initially, the next phase of the trial was expected to begin in September, but that start date has now been moved to August.

Developed by researchers at the Duke-NUS Medical School in Singapore, the uses called messenger RNA to trigger an in the body. Once injected, the vaccine prompts the body to make proteins like those of the actual virus. The body will then know what coronavirus-infected cells look like and can learn to fight them off.

Most vaccines are purely preventive, but this vaccine may also be able to treat an active case of coronavirus, the scientists added.

The vaccine activates “two arms of the immune system,” explained study author Dr. Eng Eong Ooi, deputy director of the Emerging Infectious Diseases Program at Duke-NUS Medical School in Singapore.

One “arm,” Ooi explained, prevents a coronavirus infection by teaching the body to recognize the virus. The other kills off infected cells, preventing the illness from spreading within the body.

“In preclinical studies, that’s come true—that we can develop both arms of the immune response against coronavirus,” Ooi said during a Wednesday media briefing on the vaccine.

Ooi was joined by Thomas Denny, chief operating officer of the Duke Human Vaccine Institute, and David Ridley, faculty director of the health sector management program at Duke’s Fuqua School of Business, to discuss the challenges ahead in the race to produce a safe and effective coronavirus vaccine.

Researchers around the world are developing more than 140 vaccines against the coronavirus, according to The New York Times’ vaccine tracker. There are currently 18 potential vaccines being tested for safety and correct dosing in Phase 1 or 2 , and three vaccines are in Phase 3 trials, where they are undergoing large-scale testing.

The Duke team emphasized that any expectation for a vaccine by the end of this year is overly optimistic.

“I think it’s entirely possible that a vaccine will be approved this year, but not at scale,” Ridley explained. “We might have some people vaccinated this year, but the average person won’t be vaccinated.”

Denny added, “We may have some good science by the end of the year and think we have some leading candidates. But manufacturing them to have it all administered, that’s a tall order to be ready by the beginning of 2021.”

There are currently no RNA vaccines on the market for any disease, the researchers said, but many are being tested in clinical trials, both for coronavirus and other diseases.

Most coronavirus vaccines being studied require two doses—including Moderna’s RNA vaccine—but Ooi said the vaccine being developed by Duke-NUS and the pharmaceutical company Arcturus Therapeutics is different. So far, it appears this vaccine requires only one dose because it has a replicating effect that makes the vaccine “expand in the body,” Ooi explained.

The vaccine will likely be the first of its kind to get this far in clinical trials if the trials proceed as expected.

Although there is some level of uncertainty with a unique vaccine like this one, the research thus far has demonstrated that the vaccine is safe.

“We are quite confident that given the kind of safety profile we observe with using RNA to deliver drugs, we should be able to get a fairly decent safety profile,” Ooi said. “I would think this vaccine will be tolerable and acceptable to the public.”

There are several steps and many months of testing ahead for this vaccine.

If the next phase of the trial begins in August, the vaccine will initially be tested on a small group of healthy adults. If it is shown to be safe, it may be tested on more , such as the elderly. This phase is “quite standard,” according to Ooi.

The following step, though, is less certain. In the next phase, a large population would be given either the vaccine or a placebo, and then studied to see if they are infected with the virus naturally. But the speed and efficacy of that stage depend on how common infections are at that time, Ooi explained.

“We can vaccinate the individuals and then see whether that would protect them from COVID, compared to a group where they got the placebo instead,” Ooi said. “But, if for whatever reason the disease incidence or prevalence of disease goes down, then it’ll take us a much longer time to assess efficacy.”

Even if the go according to plan, it is difficult to say when the vaccine could become available for general use. Ooi predicted this time next year “at the soonest.”

The research and development of the vaccine is being funded, in part, by the government of Singapore.


Follow the latest news on the coronavirus (COVID-19) outbreak


More information:
The U.S. Centers for Disease Control and Prevention has more on COVID-19.

Copyright © 2020 HealthDay. All rights reserved.

Citation:
Promising results mean coronavirus vaccine trial could start by August (2020, June 26)
retrieved 27 June 2020
from https://medicalxpress.com/news/2020-06-results-coronavirus-vaccine-trial-august.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



loading...
(Visited 3 times, 1 visits today)

Related posts:

Injuries shoot up after fireworks laws loosened in West Virginia
‘We can’t afford an ounce of meat’: Economic crisis strangles Lebanon
Algeria welcomes remains of fighters against colonisation from France
Neurological symptoms described in children with COVID-19
United States: In Louisiana, Cajuns are keen to preserve their identity
HIV may not worsen COVID-19 outlook
250. Split-Lebertransplantation am UKR - Biermann Medizin
Live Coronavirus Updates: U.S. Leaders Change Course
EU authorises use of remdesivir to treat coronavirus
Turkey challenges allies and enemies alike in quest for ‘larger role on world stage’
Porres neuer Chefarzt in Leverkusen
Even gut immune response is site-specific
Systemische Therapie kann jetzt mit den Krankenkassen abgerechnet werden
Inflammatory Bowel Disease Tied to Increased Dementia Risk
Macron names Jean Castex as new French prime minister
Popular chemotherapy drug may be less effective in overweight and obese women
Studie: Junge Menschen rauchen und trinken weniger
Can an Algorithm Predict the Pandemic’s Next Moves?
Death toll climbs to more than 160 in Myanmar jade mine disaster
Israeli, UAE technology firms pen deal on virus research
Netanyahu's annexation plan, China's campaign against Uighurs and Hollywood before the censors
Uniklinik Köln: Augenheilkundliche Spezialbereiche jetzt in Deutschlands größtem Krebs-Ambulatorium
Dutch report new coronavirus infection on mink farm
Berufsverband will Weiterbildungsförderung auch für Urologen
French PM Édouard Philippe and his government resign as Macron prepares cabinet reshuffle
Florida under siege as pandemic accelerates
Japan asks US to extradite two men accused of helping ex-Nissan chief Ghosn escape
MB: EU-Ratspräsidentschaft als Chance für mehr Kooperation in Gesundheitsfragen nutzen
Monkeys infected with novel coronavirus developed short-term immunity
Das sichtbare Skelett 2.0 - Biermann Medizin
Peru surpasses 10,000 coronavirus deaths: health ministry
Herzreparatur mit der Gen-Schere - Biermann Medizin
UK to end quarantine for travelers from 'low-risk' countries
Turkish court opens trial of Saudi officials in killing of journalist Khashoggi
New study reveals how the brain organizes information about odors
French court to rule on reopening probe of former Rwandan president's assassination
Study could show why heart events increase seasonally
US Senate unanimously votes to approve draconian 'Hong Kong Autonomy Act'
US new single-day Covid-19 cases hit new worldwide record of over 55,000
Study says crowdsourced data could help map urban food deserts
Police in Europe arrest over 800 users of encrypted phone system used to plot crime
Artificial intelligence brings pancreatic cancer screening one step closer to reality
The Young Cut Loose in Myrtle Beach. The Virus Followed Them Home.
Study exposes disparities in health care access in rural Southern California
Florida State University Child Care Policy Draws Backlash
Surge in domestic child abuse during pandemic, reports specialist UK children's hospital
Live Coronavirus News: Updates and Video
Marijuana use while pregnant boosts risk of children's sleep problems
US sanctions against international court staff an act of ‘revenge’, says ICC’s Fatou Bensouda
New, more infectious strain of COVID-19 now dominates global cases of virus: study
‘We disinfect everything’: Amsterdam’s red-light district re-opens
France's Macron to embark on next phase of his presidency with ‘new team’
When Your Tween Is Bored
Why are more young people getting coronavirus?
Ideen-Wettbewerb: Woche des Sehens in Corona-Zeiten
French prosecutors seek trial for football star Karim Benzema over sextape scandal
Talking With Your Teen About Anti-Racism? Be Ready to Listen
COVID-19 death risk twice as high in New York City as some countries
Turkey demands apology from France over naval incident claim
CBM-Jahresbericht 2019: Mehr Geld für die Projektarbeit
Venezuela reverses decision to expel EU ambassador
How the body fights off urinary tract infections
Riechstörungen bei COVID-19: Was wissen Mediziner aktuell?
Did a Mutation Help the Coronavirus Spread? More Evidence, but Lingering Questions
Fear spreads through Hong Kong’s pro-democracy movement after security law imposed by China
Hot flushes and night sweats linked to 70% increase in cardiovascular disease
Niedriger Cortisolspiegel trägt dazu bei, dass wir altern
Epstein's ex-girlfriend Ghislaine Maxwell arrested by FBI
Algerian court grants release of anti-government protest leader Karim Tabbou
Study reveals high prevalence of 'hidden' illnesses in people with type 2 diabetes
Heisenberg-Professur für Jennifer Andexer - Biermann Medizin
France to return remains of 24 fighters killed during colonisation of Algeria
CSIRO uses lab-grown 'lungs' to fight respiratory viruses
Krebsimmuntherapie bei Leukämie – Wie das körpereigene Abwehrsystem gestärkt werden kann
Australia Thought the Virus Was Under Control. It Found a Vulnerable Spot.
European Court of Human Rights condemns France over ‘inhuman’ living conditions for asylum-seekers
US virus cases smash daily record as global infections soar
Herzschwäche ist im Osten weitaus häufiger als im Westen
EU calls on Russia to probe 'irregularities' reported in vote granting Putin right to rule until 203...
Live Coronavirus Updates: U.S. Sets Case Record
Fires rage across Amazon rainforest, sparking fears of another disastrous summer season
Brazil surpasses 60,000 coronavirus deaths: official
Kabinett beschließt Nationale Demenzstrategie - Biermann Medizin
Closing bars to stop coronavirus spread is backed by science
Krankenhaus-Fallzahlen im SARS-CoV-2-Lockdown - Biermann Medizin
More than 100 dead in landslide at Myanmar jade mine
Novartis agrees to $642mn US settlement over kickbacks
Auf der Suche nach den Ursachen für männliche Unfruchtbarkeit
California takes step back from reopening amid virus surge
Neue Therapieoption bei schweren Infektionen, aber keine Belege für Überlegenheit
Researchers outline adapted health communications principles for the COVID-19 pandemic
Künstliche Intelligenz für die Medizintechnik
Health experts slam US for mass purchase of licensed Covid-19 drug
Travel safely with these expert tips in the age of coronavirus
Augenärzte wollen integrierte Notfallzentren ausbauen
US intelligence doubted Russia urged Taliban to kill US trips, says Trump
Why are patient and public voices absent in COVID-19 policy-making?
Neuer technischer Ansatz kann die Diagnose der pulmonalen Hypertonie verbessern
It Paid Doctors Kickbacks. Now, Novartis Will Pay a $678 Million Settlement.
Turkey to decide whether to redesignate iconic Hagia Sophia as mosque, not museum

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Complications after colonoscopy up for those aged ≥ 75

Sat Jun 27 , 2020
(HealthDay)—For individuals undergoing outpatient colonoscopy, the risk of 30-day postcolonoscopy complications is increased for those aged ≥75 years, according to a study published online June 25 in JAMA Network Open. Natalia Causada-Calo, M.D., from the University of Toronto, and colleagues examined the correlation between older age and the risk of […]